Literature DB >> 29315090

Incidence and Risk Factors for Anastomotic Failure in 1594 Patients Treated by Transanal Total Mesorectal Excision: Results From the International TaTME Registry.

Marta Penna1,2, Roel Hompes1, Steve Arnold3, Greg Wynn4, Ralph Austin4, Janindra Warusavitarne5, Brendan Moran3, George B Hanna2, Neil J Mortensen1, Paris P Tekkis2,6.   

Abstract

OBJECTIVE: To determine the incidence of anastomotic-related morbidity following Transanal Total Mesorectal Excision (TaTME) and identify independent risk factors for failure.
BACKGROUND: Anastomotic leak and its sequelae are dreaded complications following gastrointestinal surgery. TaTME is a recent technique for rectal resection, which includes novel anastomotic techniques.
METHODS: Prospective study of consecutive reconstructed TaTME cases recorded over 30 months in 107 surgical centers across 29 countries. Primary endpoint was "anastomotic failure," defined as a composite endpoint of early or delayed leak, pelvic abscess, anastomotic fistula, chronic sinus, or anastomotic stricture. Multivariate regression analysis performed identifying independent risk factors of anastomotic failure and an observed risk score developed.
RESULTS: One thousand five hundred ninety-four cases with anastomotic reconstruction were analyzed; 96.6% performed for cancer. Median anastomotic height from anal verge was 3.0 ± 2.0 cm with stapled techniques accounting for 66.0%. The overall anastomotic failure rate was 15.7%. This included early (7.8%) and delayed leak (2.0%), pelvic abscess (4.7%), anastomotic fistula (0.8%), chronic sinus (0.9%), and anastomotic stricture in 3.6% of cases. Independent risk factors of anastomotic failure were: male sex, obesity, smoking, diabetes mellitus, tumors >25 mm, excessive intraoperative blood loss, manual anastomosis, and prolonged perineal operative time. A scoring system for preoperative risk factors was associated with observed rates of anastomotic failure between 6.3% to 50% based on the cumulative score.
CONCLUSIONS: Large tumors in obese, diabetic male patients who smoke have the highest risk of anastomotic failure. Acknowledging such risk factors can guide appropriate consent and clinical decision-making that may reduce anastomotic-related morbidity.

Entities:  

Year:  2019        PMID: 29315090     DOI: 10.1097/SLA.0000000000002653

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  65 in total

Review 1.  Total Mesorectal Excision Technique-Past, Present, and Future.

Authors:  Joep Knol; Deborah S Keller
Journal:  Clin Colon Rectal Surg       Date:  2020-04-28

2.  Transanal total mesorectal excision (taTME) in a single-surgeon setting: refinements of the technique during the learning phase.

Authors:  A Caycedo-Marulanda; G Ma; H Y Jiang
Journal:  Tech Coloproctol       Date:  2018-06-28       Impact factor: 3.781

3.  Transanal total mesorectal excision: the Slagelse experience 2013-2019.

Authors:  Sharaf Karim Perdawood; Jens Kroeigaard; Marianne Eriksen; Pauli Mortensen
Journal:  Surg Endosc       Date:  2020-02-18       Impact factor: 4.584

4.  Delayed presentation of rectourethral fistula following TaTME (transanal total mesorectal excision).

Authors:  F Tirelli; M Grieco; A Biondi; F Belia; R Persiani
Journal:  Tech Coloproctol       Date:  2019-08-21       Impact factor: 3.781

5.  Is taTME delivering?

Authors:  M Gachabayov; R Bergamaschi
Journal:  Updates Surg       Date:  2019-02-22

6.  Feasibility of transanal total mesorectal excision (taTME) using the Medrobotics Flex® System.

Authors:  Heather Carmichael; Anthony P D'Andrea; Matthew Skancke; Vincent Obias; Patricia Sylla
Journal:  Surg Endosc       Date:  2019-07-26       Impact factor: 4.584

7.  Transanal total mesorectal excision for rectal cancer with indocyanine green fluorescence angiography.

Authors:  I Mizrahi; F B de Lacy; M Abu-Gazala; L M Fernandez; A Otero; D R Sands; A M Lacy; S D Wexner
Journal:  Tech Coloproctol       Date:  2018-11-14       Impact factor: 3.781

Review 8.  Future Directions.

Authors:  António S Soares; Manish Chand
Journal:  Clin Colon Rectal Surg       Date:  2020-04-28

Review 9.  Summary of Oncologic and Functional Outcomes.

Authors:  Roel Hompes; Marta Penna
Journal:  Clin Colon Rectal Surg       Date:  2020-04-28

10.  Quality of Life After Surgery for Rectal Cancer: a Comparison of Functional Outcomes After Transanal and Laparoscopic Approaches.

Authors:  Maya Xania Bjoern; Sarah Nielsen; Sharaf Karim Perdawood
Journal:  J Gastrointest Surg       Date:  2019-01-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.